Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation
- PMID: 31003450
- PMCID: PMC6521137
- DOI: 10.3390/nu11040872
Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation
Abstract
Aging is a complex phenomenon characterized by the progressive loss of tissue and organ function. The oxidative-stress theory of aging postulates that age-associated functional losses are due to the accumulation of ROS-induced damage. Liver function impairment and non-alcoholic fatty liver disease (NAFLD) are common among the elderly. NAFLD can progress to non-alcoholic steatohepatitis (NASH) and evolve to hepatic cirrhosis or hepatic carcinoma. Oxidative stress, lipotoxicity, and inflammation play a key role in the progression of NAFLD. A growing body of evidence supports the therapeutic potential of omega-3 polyunsaturated fatty acids (n-3 PUFA), mainly docosahaexenoic (DHA) and eicosapentaenoic acid (EPA), on metabolic diseases based on their antioxidant and anti-inflammatory properties. Here, we performed a systematic review of clinical trials analyzing the efficacy of n-3 PUFA on both systemic oxidative stress and on NAFLD/NASH features in adults. As a matter of fact, it remains controversial whether n-3 PUFA are effective to counteract oxidative stress. On the other hand, data suggest that n-3 PUFA supplementation may be effective in the early stages of NAFLD, but not in patients with more severe NAFLD or NASH. Future perspectives and relevant aspects that should be considered when planning new randomized controlled trials are also discussed.
Keywords: aging; non-alcoholic fatty liver disease; omega-3 fatty acids; oxidative stress.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand?Curr Opin Clin Nutr Metab Care. 2019 Mar;22(2):103-110. doi: 10.1097/MCO.0000000000000539. Curr Opin Clin Nutr Metab Care. 2019. PMID: 30601174 Free PMC article. Review.
-
Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.PLoS One. 2016 Oct 6;11(10):e0162368. doi: 10.1371/journal.pone.0162368. eCollection 2016. PLoS One. 2016. PMID: 27711128 Free PMC article.
-
Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.Adv Nutr. 2015 Nov 13;6(6):694-702. doi: 10.3945/an.115.009423. Print 2015 Nov. Adv Nutr. 2015. PMID: 26567194 Free PMC article. Review.
-
Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.Metab Syndr Relat Disord. 2016 Nov;14(9):417-430. doi: 10.1089/met.2016.0051. Epub 2016 Oct 6. Metab Syndr Relat Disord. 2016. PMID: 27710160 Review.
-
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.Crit Rev Food Sci Nutr. 2019;59(sup1):S116-S129. doi: 10.1080/10408398.2018.1544542. Epub 2018 Dec 22. Crit Rev Food Sci Nutr. 2019. PMID: 30580553 Review.
Cited by
-
Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial.Medicina (Kaunas). 2024 Aug 21;60(8):1366. doi: 10.3390/medicina60081366. Medicina (Kaunas). 2024. PMID: 39202647 Free PMC article. Clinical Trial.
-
Dietary novel alkaline protease from Bacillus licheniformis improves broiler meat nutritional value and modulates intestinal microbiota and metabolites.Anim Microbiome. 2024 Jan 6;6(1):1. doi: 10.1186/s42523-023-00287-z. Anim Microbiome. 2024. PMID: 38184648 Free PMC article.
-
A Diterpenoid, 14-Deoxy-11, 12-Didehydroandrographolide, in Andrographis paniculata Reduces Steatohepatitis and Liver Injury in Mice Fed a High-Fat and High-Cholesterol Diet.Nutrients. 2020 Feb 18;12(2):523. doi: 10.3390/nu12020523. Nutrients. 2020. PMID: 32085637 Free PMC article.
-
Multi-omic network analysis identified betacellulin as a novel target of omega-3 fatty acid attenuation of western diet-induced nonalcoholic steatohepatitis.EMBO Mol Med. 2023 Nov 8;15(11):e18367. doi: 10.15252/emmm.202318367. Epub 2023 Oct 20. EMBO Mol Med. 2023. PMID: 37859621 Free PMC article.
-
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions.Front Cell Dev Biol. 2023 May 16;11:1199519. doi: 10.3389/fcell.2023.1199519. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37261074 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- BFU2015-65937-R/Ministry of Economy, Industry and Competitiveness (MINECO-FEDER). Government of Spain.
- 67-2015/Department of Health of the Navarra Government
- CB12/03/30002/CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Carlos III Health Research Institute
- IJCI-2016-30025/"Juan de la Cierva" Grant. Ministry of Sciences, Innovation and Universities
LinkOut - more resources
Full Text Sources
Medical
Research Materials